The ocular drug delivery market was valued at US$ 16,404.32 million in 2021 and is projected to reach US$ 27,016.20 million by 2028; it is expected to grow at a CAGR of 7.4 % from 2021 to 2028.
An ocular drug delivery system (ODDS) is a dosage form, vehicle, or system intended to instill, administer, or deliver drug/medicine to the eye against any ailment or disorder involving or affecting vision. It ranges from simple sterile eye drop for the ocular surface to complex implants for intraocular tissue. Ocular drug formulations are primarily liquid forms, such as solutions, suspensions, and emulsions for treating anterior eye segment diseases. These formulations can be available in the form of advanced drug delivery systems like in-situ gel, microemulsion, nanoparticle, liposome, iontophoresis, nanosuspension, and ocular inserts.
The ocular drug delivery market has been segmented based on technology, formulation type, disease type, end user, and geography. By geography, the market is primarily segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the ocular drug delivery market, emphasizing parameters such as market trends, technological advancements, and market dynamics, along with competitive landscape analysis of the globally leading market players.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Ocular Drug Delivery Market: Strategic Insights
Market Size Value in US$ 16,404.32 million in 2021 Market Size Value by US$ 27,016.20 million by 2028 Growth rate CAGR of 7.4% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Ocular Drug Delivery Market: Strategic Insights
| Market Size Value in | US$ 16,404.32 million in 2021 |
| Market Size Value by | US$ 27,016.20 million by 2028 |
| Growth rate | CAGR of 7.4% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Growing Prevalence of Eye Disorders to Boost Ocular Drug Delivery Market Growth
The leading cause of blindness or low vision across the globe is cataract, glaucoma, age-related macular degeneration, diabetic retinopathy, and unaddressed refractive error. The majority of the global population have or had some eye disorder in their lifetime. As per the World Health Organization (WHO) report “Blindness and vision impairment” published in February 2021, around 2.2 billion people worldwide have a near or distance vision impairment. It has also estimated that the leading cause of vision loss or low vision is cataract (94 million) and uncorrected refractive errors (88.4 million). Further, the other common causes of vision loss are glaucoma (7.7 million), corneal opacities (4.2 million), diabetic retinopathy (3.9 million), and trachoma (2 million).
According to the National Eye Institute (NEI), in the US, the number of people with cataracts is expected to double from 24.4 million in 2010 to about 50 million in 2050. Similarly, as per the Factsheet Glaucoma: Facts & Figures 2019, over 3 million people in the US were living with glaucoma. Moreover, as per the Canadian Survey on Disabilities 2017, 1.5 million Canadians had a sight loss, and around 5.59 million had an eye disease which could further lead to sight loss.
Additionally, as per the Royal National Institute of Blind People in 2017, in the UK, there were around 350,000 people registered as blind and partially sighted; about 173,735 were registered for severely sight impaired; and 176,125 were registered for sight-impaired.
Technology-Based Insights
Based on technology, the ocular drug delivery market is segmented into implantable ocular drug delivery systems, particulate drug delivery systems, nano-particle drug delivery system, and others. The implantable ocular drug delivery systems segment would account for the largest market share in 2021, and the same segment is anticipated to register the highest CAGR during the forecast period.
Formulation Type-Based Insights
Based on formulation type, the ocular drug delivery market is segmented into liposomes and nanoparticles, solution, emulsion, suspension, and ointment. The solution segment would hold the largest share of the market in 2021, and it is estimated to register the highest CAGR in the market during 2021–2028. The growth of the solution segment is attributed to the increasing adoption of ocular drug delivery systems in solution forms, like eye drops and injectables.
Disease Type–Based Insights
Based on disease type, the ocular drug delivery market is segmented into glaucoma, diabetic retinopathy, dry eye syndrome, macular degeneration, cataract, diabetic macular edema, and others. The cataract segment would account for the largest market share in 2021. The market for this segment is estimated to grow at the highest CAGR from 2021 to 2028.
End User–Based Insights
Based on end user, the ocular drug delivery market is segmented into hospitals, ophthalmic clinics, and ambulatory surgical centers. The hospitals segment would hold the largest share of the market in 2021, while the ophthalmic clinics segment is estimated to register the highest CAGR in the market during the forecast period.
The COVID-19 pandemic has become the most significant challenge across the world. As this pandemic has stressed healthcare systems across the globe, prioritizing the limited resources was essential to minimize hospital admissions. However, despite increased demand for ocular therapeutics such as eye drops, ointment, and suspension, there was a shortage of these products as new consumers entered the market. Manufacturers are also experiencing raised prices and potential shortages of raw ingredients due to supply restrictions. However, as the restrictions have been lifted and businesses are resuming, the demand-supply variables are coming back to normal. This will offer several growth prospects for ocular drug delivery therapeutics.
Acquisitions, collaborations, partnerships, product launches, and expansions are commonly adopted strategies by companies to expand their footprint worldwide and meet the growing demand. The ocular drug delivery market players have been chiefly adopting the strategy of product innovation to cater to the changing customer demand across the world, which also helps them maintain their brand name globally.
Ocular Drug Delivery Market Report Scope
Company Profiles
- AbbVie Inc.
- Bausch Health Companies Inc.
- Taiwan Liposome Company, Ltd.
- Ocular Therapeutix, Inc.
- GRAYBUG VISION, INC.
- Alimera Sciences, Inc.
- Envisia Therapeutics
- Novartis AG
- EYEGATE PHARMACEUTICALS, INC
- Clearside Biomedical, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Technology, Formulation Type, Disease Type, End User and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoE, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The factors that are restraining the adoption of ocular drug delivery are several disadvantages associated with ocular drug delivery.
The Ocular drug delivery market majorly consists of the players such as players AbbVie Inc., Bausch Health Companies Inc., Taiwan Liposome Company, Ltd., Ocular Therapeutix, Inc., Graybug Vision, Inc., Alimera Sciences, Inc., Envisia Therapeutics, Novartis AG, EyeGate Pharmaceuticals, Inc, Clearside Biomedical, Inc. and among others.
The factors that are driving growth of the market are growing prevalence of eye disorders and rising research on ocular drug delivery.
Ocular drug delivery system (ODDS) is a dosage form, vehicle, or system intended for instilling, administering, or delivering drug/medicine to eye against any ailment or disorder involving or affecting vision. It ranges from simple sterile eye drop for the ocular surface to complex implants for intraocular tissue. Ocular drugs formulations are primarily available in liquid form such as solutions, suspensions, and emulsions for treating anterior eye segment diseases. These formulations can be available in the form of advanced drug delivery systems like in-situ gel, microemulsion, nanoparticle, liposome, iontophoresis, nanosuspension, and ocular inserts.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Ocular Drug Delivery Market – By Technology
1.3.2 Global Ocular Drug Delivery Market – By Formulation Type
1.3.3 Global Ocular Drug Delivery Market – By Disease Type
1.3.4 Global Ocular Drug Delivery Market – By End User
1.3.5 Global Ocular Drug Delivery Market – By Geography
2. Global Ocular Drug Delivery Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Ocular Drug Delivery Market – Market Landscape
4.1 Overview
4.1.1 North America – PEST Analysis
4.1.2 Europe– PEST Analysis
4.1.3 Asia Pacific– PEST Analysis
4.1.4 Middle East And Africa– PEST Analysis
4.1.5 South and Central America – PEST Analysis
4.2 Expert Opinions
5. Ocular Drug Delivery Market– Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Prevalence of Eye Disorders
5.1.2 Rising Research on Ocular Drug Delivery
5.2 Market Restraints
5.2.1 Disadvantages Associated with Ocular Drug Delivery
5.3 Market Opportunities
5.3.1 Increasing Awareness About Vision Care
5.4 Future Trends
5.4.1 Development of Innovative Products
5.5 Impact analysis
6. Ocular Drug Delivery Market – Global Analysis
6.1 Global Ocular Drug Delivery Market Revenue Forecast and Analysis
6.2 Global Ocular Drug Delivery Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
1. Ocular Drug Delivery Market Analysis – By Formulation Type
1.1 Overview
1.1.1 Global Ocular Drug Delivery Market, By Solution 2021 & 2028 (%)
1.2 Liposomes and Nanoparticles Market
1.2.1 Overview
1.2.2 Global Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)
1.3 Solution
1.3.1 Overview
1.3.2 Global Solution Market Revenue and Forecasts to 2028 (US$ Million)
1.4 Emulsion
1.4.1 Overview
1.4.2 Global Emulsion Market Revenue and Forecasts to 2028 (US$ Million)
1.5 Suspension
1.5.1 Overview
1.5.2 Global Suspension Market Revenue and Forecasts to 2028 (US$ Million)
1.6 Ointment
1.6.1 Overview
1.6.2 Global Ointment Market Revenue and Forecasts to 2028 (US$ Million)
2. Ocular Drug Delivery Market Analysis – By End User
2.1 Overview
2.2 Ocular Drug Delivery Market Share, by Technique, 2021 and 2028 (%)
2.3 Hospitals
2.3.1 Overview
2.3.2 Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)
2.4 Ophthalmic Clinics
2.4.1 Overview
2.4.2 Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)
2.5 Ambulatory Surgical Centers
2.5.1 Overview
2.5.2 Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)
2.6 Asia Pacific: Ocular Drug Delivery Market
2.6.1 Overview
2.6.2 Asia Pacific: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (USD Million)
2.6.3 Asia Pacific: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)
2.6.4 Asia Pacific: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)
2.6.5 Asia Pacific: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)
2.6.6 Asia Pacific: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)
2.6.7 Asia Pacific: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)
2.6.8 China: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
2.6.8.1 China: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
2.6.8.2 China: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)
2.6.8.3 China: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)
2.6.8.4 China: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)
2.6.8.5 China: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)
2.6.9 Japan: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
2.6.9.1 Japan: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
2.6.9.2 Japan: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)
2.6.9.3 Japan: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)
2.6.9.4 Japan: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)
2.6.9.5 Japan: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)
2.6.10 India: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
2.6.10.1 India: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
2.6.10.2 India: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)
2.6.10.3 India: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)
2.6.10.4 India: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)
2.6.10.5 India: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)
2.6.11 Australia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
2.6.11.1 Australia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
2.6.11.2 Australia: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)
2.6.11.3 Australia: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)
2.6.11.4 Australia: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)
2.6.11.5 Australia: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)
2.6.12 South Korea: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
2.6.12.1 South Korea: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
2.6.12.2 South Korea: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)
2.6.12.3 South Korea: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)
2.6.12.4 South Korea: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)
2.6.12.5 South Korea: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)
2.6.13 Rest of Asia Pacific: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
2.6.13.1 Rest of Asia Pacific: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
2.6.13.2 Rest of Asia Pacific: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)
2.6.13.3 Rest of Asia Pacific: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)
2.6.13.4 Rest of Asia Pacific: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)
2.6.13.5 Rest of Asia Pacific: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)
2.7 Middle East and Africa: Ocular Drug Delivery Market
2.7.1 Overview
2.7.2 Middle East & Africa: Ocular Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
2.7.3 Middle East and Africa: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
2.7.4 Middle East and Africa: Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Million)
2.7.5 Middle East and Africa: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
2.7.6 Middle East and Africa: Ocular Drug Delivery Market, by End Users – Revenue and Forecast to 2028 (US$ Million)
2.7.7 Middle East and Africa: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)
2.7.7.1 Saudi Arabia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
2.7.7.1.1 Saudi Arabia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
2.7.7.1.2 Saudi Arabia: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
2.7.7.1.3 Saudi Arabia: Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Million)
2.7.7.1.4 Saudi Arabia: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
2.7.7.1.5 Saudi Arabia: Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (US$ Million)
2.7.7.2 UAE: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
2.7.7.2.1 UAE: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
2.7.7.2.2 UAE: Ocular Drug Delivery Market , by Technology – Revenue and Forecast to 2028 (US$ Million)
2.7.7.2.3 UAE: Ocular Drug Delivery Market , by Formulation Type – Revenue and Forecast to 2028 (US$ Million)
2.7.7.2.4 UAE: Ocular Drug Delivery Market, by Disease Type– Revenue and Forecast to 2028 (US$ Million)
2.7.7.2.5 UAE: Ocular Drug Delivery Market , by End User – Revenue and Forecast to 2028 (US$ Million)
2.7.7.3 South Africa: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
2.7.7.3.1 South Africa: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
2.7.7.3.2 South Africa: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
2.7.7.3.3 South Africa: Ocular Drug Delivery Market , by Formulation Type – Revenue and Forecast to 2028 (US$ Million)
2.7.7.3.4 South Africa: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
2.7.7.3.5 South Africa: Ocular Drug Delivery Market, by End user– Revenue and Forecast to 2028 (US$ Million)
2.7.7.4 Rest of Middle East and Africa: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
2.7.7.4.1 Rest of Middle East and Africa: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
2.7.7.4.2 Rest of Middle East and Africa: Ocular Drug Delivery Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
2.7.7.4.3 Rest of Middle East and Africa: Ocular Drug Delivery Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Million)
2.7.7.4.4 Rest of Middle East and Africa: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (US$ Million)
2.7.7.4.5 Rest of Middle East and Africa: Ocular Drug Delivery Market , by End User– Revenue and Forecast to 2028 (US$ Million)
2.8 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
2.9 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
3. Industry Landscape
3.1 Overview
3.2 Growth Strategies Done by the Companies in the Market, (%)
3.3 Organic Developments
3.3.1 Overview
3.4 Inorganic Developments
3.4.1 Overview
4. Company Profiles
4.1 AbbVie Inc.
4.1.1 Key Facts
4.1.2 Business Description
4.1.3 Products and Services
4.1.4 Financial Overview
4.1.5 SWOT Analysis
4.1.6 Key Developments
4.2 Bausch Health Companies Inc.
4.2.1 Key Facts
4.2.2 Business Description
4.2.3 Products and Services
4.2.4 Financial Overview
4.2.5 SWOT Analysis
4.2.6 Key Developments
4.3 Taiwan Liposome Company, Ltd.
4.3.1 Key Facts
4.3.2 Business Description
4.3.3 Products and Services
4.3.4 Financial Overview
4.3.5 SWOT Analysis
4.3.6 Key Developments
4.4 Ocular Therapeutix, Inc.
4.4.1 Key Facts
4.4.2 Business Description
4.4.3 Products and Services
4.4.4 Financial Overview
4.4.5 SWOT Analysis
4.4.6 Key Developments
4.5 GRAYBUG VISION, INC.
4.5.1 Key Facts
4.5.2 Business Description
4.5.3 Products and Services
4.5.4 Financial Overview
4.5.5 SWOT Analysis
4.5.6 Key Developments
4.6 Alimera Sciences, Inc.
4.6.1 Key Facts
4.6.2 Business Description
4.6.3 Products and Services
4.6.4 Financial Overview
4.6.5 SWOT Analysis
4.6.6 Key Developments
4.7 Envisia Therapeutics
4.7.1 Key Facts
4.7.2 Business Description
4.7.3 Products and Services
4.7.4 Financial Overview
4.7.5 SWOT Analysis
4.7.6 Key Developments
4.8 Novartis AG
4.8.1 Key Facts
4.8.2 Business Description
4.8.3 Products and Services
4.8.4 Financial Overview
4.8.5 SWOT Analysis
4.8.6 Key Developments
4.9 EYEGATE PHARMACEUTICALS, INC
4.9.1 Key Facts
4.9.2 Business Description
4.9.3 Products and Services
4.9.4 Financial Overview
4.9.5 SWOT Analysis
4.9.6 Key Developments
4.10 Clearside Biomedical, Inc.
4.10.1 Key Facts
4.10.2 Business Description
4.10.3 Products and Services
4.10.4 Financial Overview
4.10.5 SWOT Analysis
4.10.6 Key Developments
LIST OF TABLES
Table 1. Asia Pacific: Ocular Drug Delivery Market, By Technology – Revenue and Forecast to 2028 (USD Million)
Table 2. Technology
Table 3. Asia Pacific Ocular Drug Delivery Market, By Formulation Type – Revenue and Forecast to 2028 (USD Million)
Table 4. Formulation Type
Table 5. Asia Pacific Ocular Drug Delivery Market, by Disease Type– Revenue and Forecast to 2028 (USD Million)
Table 6. Disease Type
Table 7. Asia Pacific Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 8. End User
Table 9. China: Ocular Drug Delivery Market, By Technology – Revenue and Forecast to 2028 (USD Million)
Table 10. Technology
Table 11. China: Ocular Drug Delivery Market, By Formulation Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Formulation Type
Table 13. China: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Disease Type
Table 15. China: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 16. End User
Table 17. Japan: Ocular Drug Delivery Market, By Technology– Revenue and Forecast to 2028 (USD Million)
Table 18. Technology
Table 19. Japan: Ocular Drug Delivery Market, By Formulation Type– Revenue and Forecast to 2028 (USD Million)
Table 20. Formulation Type
Table 21. Japan: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)
Table 22. Disease Type
Table 23. Japan: Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 24. End User
Table 25. India: Ocular Drug Delivery Market, By Technology– Revenue and Forecast to 2028 (USD Million)
Table 26. Technology
Table 27. India: Ocular Drug Delivery Market, By Formulation Type – Revenue and Forecast to 2028 (USD Million)
Table 28. Formulation Type
Table 29. India: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)
Table 30. Disease Type
Table 31. India: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 32. End User
Table 33. Australia: Ocular Drug Delivery Market, By Technology – Revenue and Forecast to 2028 (USD Million)
Table 34. Technology
Table 35. Australia: Ocular Drug Delivery Market, By Formulation Type– Revenue and Forecast to 2028 (USD Million)
Table 36. Formulation Type
Table 37. Australia: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)
Table 38. Disease Type
Table 39. Australia: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 40. End User
Table 41. South Korea: Ocular Drug Delivery Market, By Technology – Revenue and Forecast to 2028 (USD Million)
Table 42. Technology
Table 43. South Korea: Ocular Drug Delivery Market, By Formulation Type – Revenue and Forecast to 2028 (USD Million)
Table 44. Formulation Type
Table 45. South Korea: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)
Table 46. Disease Type
Table 47. South Korea: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 48. End User
Table 49. Rest of Asia Pacific: Ocular Drug Delivery Market, By Technology – Revenue and Forecast to 2028 (USD Million)
Table 50. Technology
Table 51. Rest of Asia Pacific: Ocular Drug Delivery Market, By Formulation Type – Revenue and Forecast to 2028 (USD Million)
Table 52. Formulation Type
Table 53. Rest of Asia Pacific: Ocular Drug Delivery Market, by Disease Type– Revenue and Forecast to 2028 (USD Million)
Table 54. Disease Type
Table 55. Rest of Asia Pacific: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 56. End User
LIST OF FIGURES
Figure 1. Ocular Drug Delivery Market Segmentation
Figure 2. Ocular Drug Delivery Market Segmentation, By Region
Figure 3. Global Ocular Drug Delivery Market Overview
Figure 4. Implantable Ocular Drug Delivery Systems Segment Held the Largest Share of the Technology Segment in Ocular Drug Delivery Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Ocular Drug Delivery Market, by Geography (US$ Million)
Figure 7. Global Ocular Drug Delivery Market – Leading Country Markets (US$ Million)
Figure 8. Global Ocular Drug Delivery Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America PEST Analysis
Figure 14. Ocular Drug Delivery Market Impact Analysis of Driver and Restraints
Figure 15. Global Ocular Drug Delivery Market – Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Ocular Drug Delivery Market – By Geography Forecast and Analysis – 2021- 2028
Figure 17. Market Positioning of Key Players in Global Ocular Drug Delivery Market
Figure 1. Global Ocular Drug Delivery Market, By Solution 2021 & 2028 (%)
Figure 2. Global Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)
Figure 3. Global Solution Market Revenue and Forecasts to 2028 (US$ Million)
Figure 4. Global Emulsion Market Revenue and Forecasts to 2028 (US$ Million)
Figure 5. Global Suspension Market Revenue and Forecasts to 2028 (US$ Million)
Figure 6. Global Ointment Market Revenue and Forecasts to 2028 (US$ Million)
Figure 7. Medical devices market Share, by Technique, 2021 and 2028 (%)
Figure 8. Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)
Figure 9. Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 10. Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)
Figure 11. Asia Pacific: Ocular Drug Delivery Market, by Key Country – Revenue (2021) (USD Million)
Figure 12. Asia Pacific Ocular Drug Delivery Market Revenue and Forecast to 2028 (USD Million)
Figure 13. Asia Pacific: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)
Figure 14. China: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
Figure 15. Japan: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
Figure 16. India: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
Figure 17. Australia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
Figure 18. South Korea: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
Figure 19. Rest of Asia Pacific: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)
Figure 20. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
The List of Companies - Ocular Drug Delivery Market
- AbbVie Inc.
- Bausch Health Companies Inc.
- Taiwan Liposome Company, Ltd.
- Ocular Therapeutix, Inc.
- GRAYBUG VISION, INC.
- Alimera Sciences, Inc.
- Envisia Therapeutics
- Novartis AG
- EYEGATE PHARMACEUTICALS, INC
- Clearside Biomedical, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Ocular Drug Delivery Market
Sep 2021
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)
Sep 2021
Mobile Cleanroom Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography
Sep 2021
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Sep 2021
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
Sep 2021
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Sep 2021
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Fall Management Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensor Pads, Floor Mat, Hip Protectors, Alert Systems, Communication Devices, and Other Products), Application (Fall Detection Systems, Fall Prevention Equipment, and Post-Fall Monitoring and Response Systems), Age Group [Elderly Population (65 and Above) and Adults (18–64 years)], End User (Hospitals and Clinics, Nursing Homes, Home Care Settings, and Other End Users), and Geography
Sep 2021
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Get Free Sample For